GlassScriptPhysician profile
Badar H Syed
NPI 1629038179
$40,571.53
in general payments reported to CMS, 2019-2025
80 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,213 · 2020: $1,958 · 2021: $3,736 · 2022: $3,179 · 2023: $6,734 · 2024: $12K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $9,320 · Travel and Lodging: $5,093 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,900.00 |
| Food and Beverage | $9,320.34 |
| Travel and Lodging | $5,093.16 |
| Education | $172.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $22,967.98 | 2019-2025 | Nuplazid |
| Abbvie INC. | $1,367.84 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Ucb, INC. | $1,270.15 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Sunovion Pharmaceuticals INC. | $1,108.16 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $931.14 | 2019-2025 | |
| Eisai INC. | $785.26 | 2019-2025 | |
| Amgen INC. | $727.18 | 2019-2025 | Uplizna, Aimovig |
| Supernus Pharmaceuticals, INC. | $627.91 | 2019-2022 | |
| Harmony Biosciences LLC | $619.50 | 2020-2025 | Wakix |
| Neurocrine Biosciences, INC. | $600.39 | 2020-2025 | Ingrezza, Ongentys |
| Biogen, INC. | $522.46 | 2019-2025 | Leqembi, Vumerity, Tysabri |
| Catalyst Pharmaceuticals, INC. | $489.75 | 2021-2025 | Fycompa |
| Teva Pharmaceuticals USA, INC. | $437.83 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Otsuka America Pharmaceutical, INC. | $422.61 | 2023-2025 | Rexulti, Nuedexta |
| Mdd US Operations, LLC | $403.43 | 2020-2025 | Gocovri, Gocovri |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $399.51 | 2019-2025 | Ultomiris |
| Sk Life Science, INC. | $376.82 | 2020-2025 | |
| Lilly USA, LLC | $374.35 | 2019-2025 | Amyvid, Emgality, Kisunla |
| Lundbeck LLC | $359.80 | 2022-2025 | Vyepti, Rexulti |
| Grifols USA, LLC | $358.98 | 2021-2025 | Gamunex-C, Xembify |
| Janssen Biotech, INC. | $286.31 | 2025 | |
| Pfizer INC. | $282.98 | 2019-2025 | |
| Azurity Pharmaceuticals, INC. | $276.43 | 2023-2025 | Horizant, Horizant, Azmiro |
| Adamas Pharmaceuticals, INC. | $273.98 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $268.08 | 2020-2025 | |
| Amneal Pharmaceuticals LLC | $268.07 | 2019-2025 | Crexont, Rytary, Ongentys 50mg Capsules 30 |
| Avanir Pharmaceuticals, INC. | $243.16 | 2020-2022 | |
| Neurelis, INC. | $203.96 | 2020-2025 | Valtoco |
| Genzyme Corporation | $194.24 | 2019-2022 | |
| Emd Serono, INC. | $174.05 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $169.56 | 2022 | |
| Allergan, INC. | $167.35 | 2020-2022 | |
| Axsome Therapeutics, INC. | $148.12 | 2023-2025 | Sunosi, Symbravo |
| Janssen Pharmaceuticals, INC | $135.38 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $131.84 | 2022-2025 | Quviviq, Quviviq |
| Kyowa Kirin, INC. | $126.44 | 2020-2022 | |
| Vanda Pharmaceuticals INC. | $124.68 | 2024-2025 | Ponvory |
| Acorda Therapeutics, INC | $119.46 | 2023-2024 | Inbrija |
| Argenx US, INC. | $118.15 | 2022-2025 | Vyvgart Hytrulo |
| Csl Behring | $111.50 | 2019-2025 | Hizentra |
| Merz Pharmaceuticals, LLC | $99.87 | 2021-2025 | Xeomin, Inbrija |
| Arbor Pharmaceuticals, INC. | $88.19 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $85.66 | 2021 | |
| Corium, LLC | $68.14 | 2022-2023 | Adlarity |
| Aprecia Pharmaceuticals, LLC | $65.25 | 2020-2021 | |
| Banner Life Sciences, LLC | $64.86 | 2021 | |
| Ge Healthcare | $59.64 | 2025 | |
| Upsher-Smith Laboratories LLC | $58.11 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $56.79 | 2020-2023 | Belsomra |
| Inspire Medical Systems, INC. | $56.14 | 2024 | Inspire |
| Avion Pharmaceuticals | $55.29 | 2022 | |
| Scilex Pharmaceuticals INC. | $55.08 | 2022-2024 | Ztlido |
| Forte Bio-Pharma LLC | $54.56 | 2025 | Tanlor |
| Livanova USA, INC. | $52.59 | 2022-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Sumitomo Pharma America, INC. | $52.08 | 2023 | Aptiom |
| E.R. Squibb & Sons, L.L.C. | $50.47 | 2020-2021 | |
| Almatica Pharma LLC | $47.24 | 2021 | |
| Kedrion Biopharma, INC. | $42.46 | 2024-2025 | Rhogam Ultra-Filtered Plus, Gammaked, Albuked |
| Celgene Corporation | $42.36 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $35.19 | 2020-2021 | |
| Zogenix INC. | $34.45 | 2021 | |
| Impel Pharmaceuticals INC. | $29.30 | 2023 | Trudhesa |
| Boston Scientific Corporation | $28.49 | 2025 | General - Dbs |
| Noctrix Health, INC. | $27.12 | 2025 | Nidra |
| Natus Medical Incorporated | $25.22 | 2019 | |
| Merz North America, INC. | $23.34 | 2019 | |
| Mallinckrodt Hospital Products INC. | $21.41 | 2021 | |
| Metacel Pharmaceuticals LLC | $19.26 | 2022 | |
| Averitas Pharma INC. | $19.17 | 2023 | Qutenza |
| Cycle Pharmaceuticals INC | $19.07 | 2025 | Tascenso Odt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.87 | 2024 | Caplyta |
| Vertical Pharmaceuticals, LLC | $18.47 | 2019 | |
| Aquestive Therapeutics, INC. | $18.07 | 2022 | |
| Assertio Therapeutics, INC. | $17.69 | 2020 | |
| C2n Diagnostics, LLC | $16.86 | 2025 | Precivityad2 |
| Mallinckrodt Enterprises LLC | $15.80 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.71 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.50 | 2021 | |
| Aucta Pharmaceuticals, INC. | $13.02 | 2025 | Motpoly Xr |
| Impel Pharmaceuticals LLC | $10.95 | 2024 | Trudhesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Badar Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.